Get email alerts on the Opioid Settlement topic
No spam. Unsubscribe anytime.
Committee introduces resolution to let Lancaster join additional opioid manufacturer settlements
Summary
The Law Committee proposed Temp Res #67-25 to authorize Lancaster to join additional opioid pharmaceutical-manufacturer settlements within the One Ohio Settlement; Law Director Hall cautioned some company names are generic and may not be recognizable.
Mrs. Crites, speaking for the Law Committee on Aug. 11, introduced Temp Res #67-25 to authorize the City to join a set of additional opioid pharmaceutical-manufacturer settlements that are part of the broader One Ohio Settlement.
Law Director Hall said the named manufacturers in the settlement documents may not be readily recognizable because they are listed under generic or corporate names. The minutes do not record a committee vote on the resolution; the item was introduced for further consideration and will proceed through the council's resolution process.
The committee noted the item as part of ongoing municipal participation in opioid-related settlements but provided no dollar amounts or distribution details in the committee minutes.
AI generated
The text on this page is AI generated. Summaries, highlights, analysis, and video transcripts are all produced from the original source material.
AI can make mistakes, so if you spot one, and we will fix it for everyone.
Note: the source content is unaltered by us. Any content source we link to, be it a video, an audio recording, or a document, is presented exactly as its publisher released it. That publisher is usually a government body, sometimes an individual official or another organisation.
